HART & TRINEN, LLP
                                ATTORNEYS AT LAW
                             1624 Washington Street
                                Denver, CO 80203
William T. Hart, P.C.              ________           Email:  harttrinen@aol.com
Donald T. Trinen                                      Facsimile:  (303) 839-5414
                                 (303) 839-0061

                                  July 17, 2007

Sonia Barros
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549

      Re:   Tongji Healthcare Group, Inc.
            Registration Statement on Form SB-2
            File No. 333-140645

      This office represents Tongji Healthcare Group, Inc. (the "Company"). In
reference to the staff's letter dated June 22, 2007 we would like to address
comments 1, 2, and 3 before filing an amendment to the registration statement.


C-1    The risk factor which is the subject of this comment has been revised to
       read as follows:

           The Chinese health care industry is extensively regulated and if we
           are unable to comply with all regulations we may lose our right to be
           reimbursed for medicare patients be fined or could lose our license
           to operate our hospital.

           The healthcare industry in China is subject to extensive governmental
           laws and regulations relating to licensure, conduct of operations,
           ownership of facilities, addition of facilities and services, and
           fees for services. These laws and regulations are complex and, in
           many instances, the healthcare industry does not have the benefit of
           significant regulatory or judicial interpretation.

           During year ended December 31, 2006 we derived approximately 41% of
           our revenues from services provided to Medicare patients. The
           medicare accreditation is valid for only one year and must be renewed
           on an annual basis. If we do not maintain high standards for patient
           care the agencies which administer the Medicare program have the
           authority to terminate our ability to receive reimbursement from the
           Medicare funds.

           Fines for violation of regulations could be as high as $650 per
           incident. If the license to operate our hospital was revoked we would
           have to cease operations and it would take at least six months before
           we could be approved for a new license.


                                                                               1





           See the "Business" section of this prospectus for more information
           concerning these laws and regulations.

C-2    In the Risk Factor which is the subject of this comment the Company has
       briefly described the nature of the proposed regulations which, if
       implemented, could:

          o    prevent sales of drugs and medications by hospitals,
          o    change the prices the Company can charge for medical services and
               medications, and
          o    increase the number of healthcare facilities.

       Insofar as quantifying the potential impact of these regulations, the
       risk factor states that (i) during the year ended December 31, 2006
       approximately 50% of the Company's revenues were derived from the sales
       of drugs and medications and (ii) increasing the number of healthcare
       facilities would increase competition. However, the risk factor also
       states that the Company cannot predict the impact of these proposed
       changes.

       Based upon the foregoing, we believe that the Company, in the risk factor
       as written, has either provided all disclosures requested by the staff
       which the Company is able to provide or has indicated why it is unable to
       provide the other disclosures requested by the staff.

C-3    This risk factor which we propose to add reads as follows:

           Fluctuations in exchange rates could reduce our revenues.

           Although we use the United States dollar for financial reporting
           purposes, all of the transactions by our operating subsidiary are
           denominated in PRC's RMB. Although the exchange rate of the RMB may
           fluctuate wildly against the U.S. dollars we do not currently engage
           in hedging activities to protect against foreign currency risks. Even
           if we chose to engage in hedging activities, we may not be able to do
           so effectively. Our assets and liabilities are translated at the
           exchange rates as of the balance sheet date and our income and
           expenditures are translated at the average exchange rate of the year.
           The exchange rates of RMB to the U.S. dollar (i.e. the number of RMB
           that could be purchased for one U.S. dollar) declined from 8.0702 at
           December 31, 2005 to 7.8217 at December 31, 2006. The average
           exchange rate for the year ended December 31, 2005 was 8.1734 and
           declined to 7.9487 during the year ended December 31, 2006. The
           exchange rate also declined between March 31, 2007 and December 31,
           2006. Due to the difference in the exchange rates, we recorded small
           amounts as comprehensive income for the years ended December 31, 2006
           and 2005, and for the three months ended March 31, 2007 and 2006.


                                                                               2



           However, if the exchange rate were to increase we would experience a
           currency translation loss for purposes of our comprehensive income.

      Please advise if our proposed responses to these comments are acceptable
to the staff.

                                           Very Truly Yours,

                                           HART & TRINEN, L.L.P.



                                           William T. Hart




WTH:ap